-
Protein Sciences Corp., Meriden, Conn. UMN Pharma Inc. (Tokyo:4585), Akita, Japan Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Ildong Pharmaceutical Co. Ltd., Seoul, South Korea Product: Flublok (UMN-0502, ASP7374) …
Published on 2/18/2013
-
Genelux Corp., San Diego, Calif. Product: GLV-1h68 (GL-ONC1) Business: Pulmonary Molecular target: NA Description: Genetically stable modified vaccinia virus that incorporates green fluorescent protein (GFP) to enable …
Published on 2/18/2013
-
Medgenics Inc. (LSE:MEDU; NYSE-M:MDGN), Vienna, Va. Product: Infradure Business: Infectious Molecular target: NA Description: Autologous tissue explants that deliver sustained interferon (IFN) alpha using Medgenics' …
Published on 2/18/2013
-
Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Product: LAI287, NN1436 Business: Endocrine/Metabolic Molecular target: NA Description: Long-acting insulin analog Indication: Treat Type I diabetes Endpoint: …
Published on 2/18/2013
-
Activaero GmbH, Gemuenden, Germany Product: Lysine acetylsalicylate glycine (LASAG) Business: Infectious Molecular target: NA Description: LASAG delivered using Activaero's FAVORITE inhalation delivery technology …
Published on 2/18/2013
-
Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Product: MK-3102 Business: Endocrine/Metabolic Molecular target: Dipeptidyl peptidase-4 (DPP-4) Description: Once-weekly, oral dipeptidyl peptidase-4 (DPP-4) …
Published on 2/18/2013
-
Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI), Bothell, Wash. Product: OGX-427 Business: Cancer Molecular target: Heat shock protein 27 (Hsp27) Description: …
Published on 2/18/2013
-
Nanomix Inc., Emeryville, Calif. Product: Omega-3 Cardiac Panel Business: Diagnostic Molecular target: NA Description: Mobile in vitro diagnostic platform to quantitatively determine cardiac troponin I, myoglobin and …
Published on 2/18/2013
-
Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Cytokinetics Inc. (NASDAQ:CYTK), South San Francisco, Calif. Product: Oral omecamtiv mecarbil Business: Cardiovascular Molecular target: Cardiac myosin Description: …
Published on 2/18/2013
-
Oncoethix S.A., Lausanne, Switzerland Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508), Osaka, Japan Product: OTX015 Business: Cancer Molecular target: Bromodomain containing 2 (BRD2); Bromodomain containing 3 (…
Published on 2/18/2013
-
PledPharma AB (SSE:PLED), Stockholm, Sweden Product: PledOx calmangafodipir Business: Hematology Molecular target: Superoxide dismutase 2 mitochondrial (SOD2) (MNSOD) Description: Pyridoxyl ethyldiamine (PLED) analog in…
Published on 2/18/2013
-
Adventrx Pharmaceuticals Inc. (NYSE-M:ANX), San Diego, Calif. Product: Purified poloxamer 188 (ANX-188) Business: Hematology Molecular target: NA Description: Antithrombotic poloxamer that adheres to hydrophobic …
Published on 2/18/2013
-
Dompe Farmaceutici S.p.A., Milan, Italy Product: Recombinant human nerve growth factor (rhNGF) Business: Ophthalmic Molecular target: NA Description: Recombinant human nerve growth factor (rhNGF) Indication: Treat stage…
Published on 2/18/2013
-
Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Product: SAR407899 Business: Renal Molecular target: Rho kinase Description: Rho kinase inhibitor Indication: Treat diabetic nephropathy Endpoint: NA Status: Development …
Published on 2/18/2013
-
Synageva BioPharma Corp. (NASDAQ:GEVA), Lexington, Mass. Product: Sebelipase alfa (rhLAL) (formerly SBC-102) Business: Endocrine/Metabolic Molecular target: NA Description: Recombinant human lysosomal acid lipase (LAL) …
Published on 2/18/2013
-
Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Tamiflu oseltamivir Business: Infectious Molecular target: Neuraminidase (NEU1) (SIAL1) Description: …
Published on 2/18/2013
-
Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Tamiflu oseltamivir Business: Infectious Molecular target: Neuraminidase (NEU1) (SIAL1) Description: …
Published on 2/18/2013
-
LFB S.A., Les Ulis, France TG Therapeutics Inc. (OTCBB:TGTX), New York, N.Y. Ildong Pharmaceutical Co. Ltd., Seoul, South Korea Product: Ublituximab (LFB-R603, TGTX-1101) Business: Cancer Molecular target: CD20 …
Published on 2/18/2013
-
Cardiorentis AG, Zug, Switzerland Product: Ularitide (ULA01) Business: Cardiovascular Molecular target: NA Description: Intravenous infusion of chemically synthesized form of urodilatin Indication: Treat acute …
Published on 2/18/2013
-
Xencor Inc., Monrovia, Calif. Product: XmAb5871 Business: Autoimmune Molecular target: CD19; Fc gamma receptor IIb (CD32B) (FCGR2B) Description: Humanized mAb targeting CD19 and Fc gamma receptor IIb (CD32B; FCGR2B) …
Published on 2/18/2013
-
OxiGene Inc. (NASDAQ:OXGN), South San Francisco, Calif. Product: Zybrestat fosbretabulin (Combretastatin A4P, Zybrestat) Business: Cancer Molecular target: Tubulin Description: A4 prodrug phosphatase-activated tumor …
Published on 2/18/2013
-
Ziopharm Oncology Inc. (NASDAQ:ZIOP), New York, N.Y. Product: Zymafos palifosfamide (ZIO-201) Business: Cancer Molecular target: DNA Description: DNA cross-linker shown to bypass resistance mediated by aldehyde …
Published on 2/18/2013
-
Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Aleglitazar (R1439, RG1439) Business: Cardiovascular Molecular target: Peroxisome proliferation activated receptor (PPAR) alpha; Peroxisome proliferation …
Published on 2/11/2013
-
Apogenix GmbH, Heidelberg, Germany Product: Apocept (APG101) Business: Cancer Molecular target: CD95 ligand Description: Soluble fusion protein combining the extracellular domain of CD95 and the Fc portion of IgG …
Published on 2/11/2013
-
Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151), Tokyo, Japan Product: Aranesp darbepoetin alfa (NESP) (KRN321) Business: Hematology Molecular target: Erythropoietin (EPO) …
Published on 2/11/2013